Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3+
SponsorNational Cancer Institute (NCI)
About this trial
Background:
\- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blood or cheek swab samples from people having cancer treatment to study these genes.
Objectives:
\- To obtain a blood or cheek swab sample to study genetic differences that may affect cancer treatment.
Eligibility:
\- Individuals with cancer who are being treated at the National Cancer Institute.
Design:
* Participants will provide a blood sample for study. * Participants who have blood-based cancer, such as leukemia, will provide a cheek swab sample. * If the blood or cheek swab sample does not have enough genetic material for analysis, an additional sample may be collected.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.
Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.
Age >= 3 years old
Disqualifiers
None
Trial population
Any patient enrolled on an IRB approved NIH Intramural Research Program therapeutic clinical trial with cancer, other tumors, or possible genetic tumor predisposition syndromes.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,100 Participants
are grouped into 1 trial groupGroup A: 1/ Patients with cancer, other tumors, or possible genetic tumor
Trial outcomes
Primary outcomes
1
Obtain and analyze the genomic DNA from patients with cancer, other tumors, or possible genetic tumor predisposition syndromes on a therapeutic clinical trial.
to determine the association between SNP parameters and clinical response and/or toxicity from genomic DNA extracted from patient samples
Time frame
duration of studySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov